Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)
Clinical trial NCT02223117 · COMPLETED
Trial details
- NCT number
- NCT02223117
- Sponsor
- Cellphire Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-07-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.